Respiratory Therapy HOME Products Aerogen Opportunity

Moderate-severe COPD 8 million
Pediatric Asthma 6 million
Cystic Fibrosis 30 thousand

Initial Target Market U.S. Patients

Previous slide

Next slide

Back to first slide

View graphic version